Why the study?
Catheter ablation is a common treatment for AF, but outcomes of same-day discharge compared with overnight stay in outpatients needed evaluation.
Does same day discharge after catheter ablation for atrial fibrillation result in similar safety and efficacy outcomes compared to overnight stay?
Does same day discharge after catheter ablation for atrial fibrillation result in similar safety and efficacy outcomes compared to overnight stay?
Same-day discharge after catheter ablation for atrial fibrillation appears safe and effective, with comparable complication and recurrence rates to overnight stay.
May support SDD after selected outpatient AF ablations; leaves open practice change pending prospective trials.
BACKGROUND: Catheter ablation (CA) is a common treatment for atrial fibrillation (AF). This study evaluated outcomes of same day discharge (SDD) versus overnight stay (ONS) among AF patients undergoing outpatient CA. METHODS: The Optum SES Clinformatics Extended Data Mart database was used to identify patients ≥18 years of age undergoing outpatient CA for AF (2016-2020). Eligible patients were indexed to the date of first CA and classified into SDD and ONS groups based on the length of service. A 1:3 propensity score matching was used to create comparable SDD:ONS samples. The primary safety outcome was CA-related complications within 30 days of index procedure. The primary efficacy outcome was AF recurrence within 1 year. Cox proportional hazards models were estimated for outcome comparison. RESULTS: In the postmatch 30-day cohort for safety evaluation, there were 6600 patients (1660 [25.2%] SDD; 4940 [74.8%] ONS), with a mean age of 66.6 years. There was no significant difference in the 30-day composite rate of postablation complications (4.7% [78/1660] vs. 3.8% [187/4940]; p = 0.100) and 1-year composite rate of AF recurrence (14.3% [142/996] vs. 14.5% [430/2972]; p = 0.705) between the SDD and ONS groups. CONCLUSION: This study demonstrated that SDD following CA to treat patients with AF is safe, with low rates of postablation complications and AF recurrence, which were comparable to rates in patients with an ONS after CA.
No takes yet. Share an insight, caveat, or question.
Field et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: